SEC Form D · filed August 1, 2022
Mira1a Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Darren E. Klinck · VANCOUVER, British Columbia, CanadaExecChristian J. Milau · VANCOUVER, British Columbia, CanadaDirectorWayne Linsley · Sarasota, FLDirectorJeff Pavell · Sarasota, FLDirectorNicholas Tuosto · Santa Monica, CADirectorAdam Kaplin, Md, Phd · Baltimore, MDExecBrad Kroenig · Baltimore, MDDirectorChris Chapman, Md · Baltimore, MDDirectorJeff Fox · Little Rock, ARDirectorPaul Rivard, Esq · Baltimore, MDExecEric Weisblum · Sarasota, FLExecSimon Cawdery · George Town, Cayman IslandsDirectorJosh Silverman · Baltimore, MDDirectorPhilip Sanderson · Santa Monica, CADirectorTalhia Tuck, Jd · Baltimore, MDDirectorWhite Post Opportunity GP, LLC · San Antonio, TXDirectorDave Vorhoff · Baltimore, MDDirectorChristopher Zarou · Garden City, NYExecWhite Post Investments, LP · San Antonio, TXDirectorShannon K. Jagodinski · George Town, Grand Cayman, Cayman IslandsExecKevin Munoz · Sarasota, FLDirectorTimothy T. Barry · VANCOUVER, British Columbia, CanadaDirectorDarin Myman · New Brunswick, NJExecBrian D. Edgar · VANCOUVER, British Columbia, CanadaDirectorG. W. Carson · VANCOUVER, British Columbia, CanadaExecVera W. Kobalia · VANCOUVER, British Columbia, CanadaExecJames Mcnulty, Cpa · Baltimore, MDExecJohn Banta · McLean, VAExecJude Uzonwanne · Baltimore, MDExecHugh Mccoll Iii · Baltimore, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗